Vulval lichen sclerosus: An Australasian management consensus
- PMID: 34117779
- DOI: 10.1111/ajd.13594
Vulval lichen sclerosus: An Australasian management consensus
Abstract
Background/objectives: Vulval lichen sclerosus (VLS) is a chronic inflammatory skin condition predominantly affecting the anogenital region in women and children. To date, there is lack of agreement amongst experts on a severity scale to aid assessment, research and treatment stratification on VLS. Furthermore, literature on best practice for long-term management of VLS is lacking. The aim of this consensus is to provide broad guidelines on the short and long-term management of VLS.
Methods: An initial focus group of Australasian experts in vulval dermatology developed a draft consensus statement for the management of VLS. Based on the results of the draft statement, a consensus panel of 22 Australasian experts, comprised of the initial and additional members, participated in an anonymous four-stage eDelphi process. Round 1 involved generation and voting on statements from the draft consensus statement developed by the focus group. In Rounds 2, 3 & 4, panel members were presented formal feedback from previous rounds and asked to indicate their level of agreement. Consensus was reached if there was ≥70% agreement on the importance of an item in the 4 (agree) to 5 (strongly agree) range.
Results: The expert panel, with a total of 504 collective years of experience in the field of VLS, reached consensus on a core set of 51 management statements related to diagnosis, severity, initial and long-term management, follow-up, and complications of VLS.
Conclusions: This study has identified a set of management statements for VLS that may be useful in clinical practice in the Australasian population.
Keywords: consensus; lichen sclerosus; management; recommendations; vulva.
© 2021 The Australasian College of Dermatologists.
References
REFERENCES
-
- Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas. J. Dermatol. 1996; 37: 12-8.
-
- Van de Nieuwenhof HP, Meeuwis KA, Nieboer TE et al. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J. Psychosom. Obstet. Gynaecol. 2010; 31: 279-84.
-
- Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists. Am. J. Clin. Dermatol. 2018; 19: 695-706.
-
- Kirtschig G, Cooper S, Aberer W et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J. Eur. Acad. Dermatol. Venereol. 2017; 31: e81-e83.
-
- Bleeker MCG, Visser PJ, Overbeek LIH et al. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2016; 25: 1224-30.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
